US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 0.1170
  • +0.0227+24.07%
Close Apr 25 16:00 ET
  • 0.1017
  • -0.0153-13.08%
Post 18:35 ET
5.18MMarket Cap-119P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
80.78%14.54M
-45.83%2.12M
211.92%2.07M
548.43%3.92M
124.55%6.43M
115.17%8.04M
328.01%3.91M
-23.97%663K
-36.38%605K
186.01%2.86M
Selling and administrative expenses
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
-27.13%454K
41.99%1.06M
-General and administrative expense
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
-27.13%454K
41.99%1.06M
Research and development costs
284.03%10.36M
80.18%982K
367.53%907K
1,904.64%3.03M
201.16%5.45M
115.15%2.7M
39.74%545K
-30.22%194K
-53.96%151K
600.78%1.81M
Operating profit
-80.78%-14.54M
45.83%-2.12M
-211.92%-2.07M
-548.43%-3.92M
-124.55%-6.43M
-115.17%-8.04M
-328.01%-3.91M
23.97%-663K
36.38%-605K
-186.01%-2.86M
Net non-operating interest income expense
81.93%-206K
101.92%22K
800.00%9K
5,600.00%57K
-14,850.00%-295K
-16,385.71%-1.14M
-114,500.00%-1.14M
0.00%1K
-50.00%1K
-33.33%2K
Non-operating interest income
530.00%126K
37.50%22K
800.00%9K
5,600.00%57K
1,750.00%37K
185.71%20K
1,500.00%16K
0.00%1K
-50.00%1K
-33.33%2K
Non-operating interest expense
-71.38%332K
--0
--0
--0
--332K
--1.16M
--1.16M
--0
--0
--0
Other net income (expense)
-23.69%4.26M
2.71M
2.57M
-150K
-878K
5.58M
Gain on sale of security
-23.69%4.26M
--2.71M
--2.57M
---150K
---878K
--5.58M
----
----
----
----
Income before tax
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
-186.67%-2.86M
Income tax
Net income
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
-186.67%-2.86M
Net income continuous Operations
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
36.35%-604K
-186.67%-2.86M
Minority interest income
-117.65%-111K
54.90%-23K
-13K
-9K
-66K
-51K
-51K
0
0
0
Net income attributable to the parent company
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
36.35%-604K
-186.67%-2.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
36.35%-604K
-186.67%-2.86M
Basic earnings per share
39.88%-73.5
-79.24%1.8752
113.33%4.5
-26.83%-39
-64.63%-253.125
50.46%-122.25
116.28%9.0336
43.04%-33.75
54.44%-30.75
-127.78%-153.75
Diluted earnings per share
39.88%-73.5
-79.24%1.8752
113.33%4.5
-26.83%-39
-64.63%-253.125
50.46%-122.25
116.28%9.0336
43.04%-33.75
54.44%-30.75
-127.78%-153.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 80.78%14.54M-45.83%2.12M211.92%2.07M548.43%3.92M124.55%6.43M115.17%8.04M328.01%3.91M-23.97%663K-36.38%605K186.01%2.86M
Selling and administrative expenses -21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K-27.13%454K41.99%1.06M
-General and administrative expense -21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K-27.13%454K41.99%1.06M
Research and development costs 284.03%10.36M80.18%982K367.53%907K1,904.64%3.03M201.16%5.45M115.15%2.7M39.74%545K-30.22%194K-53.96%151K600.78%1.81M
Operating profit -80.78%-14.54M45.83%-2.12M-211.92%-2.07M-548.43%-3.92M-124.55%-6.43M-115.17%-8.04M-328.01%-3.91M23.97%-663K36.38%-605K-186.01%-2.86M
Net non-operating interest income expense 81.93%-206K101.92%22K800.00%9K5,600.00%57K-14,850.00%-295K-16,385.71%-1.14M-114,500.00%-1.14M0.00%1K-50.00%1K-33.33%2K
Non-operating interest income 530.00%126K37.50%22K800.00%9K5,600.00%57K1,750.00%37K185.71%20K1,500.00%16K0.00%1K-50.00%1K-33.33%2K
Non-operating interest expense -71.38%332K--0--0--0--332K--1.16M--1.16M--0--0--0
Other net income (expense) -23.69%4.26M2.71M2.57M-150K-878K5.58M
Gain on sale of security -23.69%4.26M--2.71M--2.57M---150K---878K--5.58M----------------
Income before tax -191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K-186.67%-2.86M
Income tax
Net income -191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K-186.67%-2.86M
Net income continuous Operations -191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K36.35%-604K-186.67%-2.86M
Minority interest income -117.65%-111K54.90%-23K-13K-9K-66K-51K-51K000
Net income attributable to the parent company -192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K36.35%-604K-186.67%-2.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K36.35%-604K-186.67%-2.86M
Basic earnings per share 39.88%-73.5-79.24%1.8752113.33%4.5-26.83%-39-64.63%-253.12550.46%-122.25116.28%9.033643.04%-33.7554.44%-30.75-127.78%-153.75
Diluted earnings per share 39.88%-73.5-79.24%1.8752113.33%4.5-26.83%-39-64.63%-253.12550.46%-122.25116.28%9.033643.04%-33.7554.44%-30.75-127.78%-153.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg